Stay updated on Cabozantinib for CNS Tumors in Children Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for CNS Tumors in Children Clinical Trial page.

Latest updates to the Cabozantinib for CNS Tumors in Children Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page removes a general funding-related operating status notice; this does not affect core trial content such as eligibility, status, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedThe study details page appears unchanged between the two screenshots; core sections such as study design, eligibility criteria, and primary/secondary outcomes remain as listed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange Detected- Updated the page to v3.2.0 and added a government-operational status notice clarifying potential delays and open status of NIH Clinical Center. - Removed the previous version tag v3.1.0.SummaryDifference3%

- Check78 days agoChange DetectedUpdated naming to mirror current medical terminology: replace 'Anaplastic astrocytoma' with 'Astrocytoma, anaplastic' and bump version from v3.0.2 to v3.1.0.SummaryDifference0.2%

- Check93 days agoChange DetectedMinor update: the revision changed from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed; no substantive changes to core content, pricing, stock availability, or time-slot information.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib for CNS Tumors in Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for CNS Tumors in Children Clinical Trial page.